{
    "Trade/Device Name(s)": [
        "Randox Maternal Controls Level 1, Level 2 and Level 3"
    ],
    "Submitter Information": "Randox Laboratories Limited",
    "510(k) Number": "K113720",
    "Predicate Device Reference 510(k) Number(s)": [],
    "Regulatory Class": "Class I, reserved",
    "Product Code(s)": [
        "JJY"
    ],
    "Summary Letter Date": "September 7, 2012",
    "Summary Letter Received Date": "September 10, 2012",
    "Submission Date": "",
    "Regulation Number(s)": [
        "21CFR862.1660"
    ],
    "Regulation Name(s)": [
        "Quality Control Material (Assayed and Unassayed)"
    ],
    "Analyte Class(es)": [
        "chemistry"
    ],
    "Analyte(s)": [
        "Unconjugated Estriol",
        "Total Beta Human Chorionic Gonadotrophin"
    ],
    "Specimen Type(s)": [
        "Serum"
    ],
    "Specimen Container(s)": [],
    "Instrument(s)/Platform(s)": [],
    "Method(s)/Technology(ies)": [],
    "Methodologies": [],
    "Submission Type(s)": [
        "Control",
        "Quality control material"
    ],
    "Document Summary": "FDA 510(k) summary for Randox Maternal Controls Levels 1, 2 and 3 used for quality control of Unconjugated Estriol and Total Beta Human Chorionic Gonadotrophin methods in clinical chemistry.",
    "Indications for Use Summary": "Intended for in vitro diagnostic use in the quality control of Unconjugated Estriol and Total Beta Human Chorionic Gonadotrophin methods on clinical chemistry systems.",
    "fda_folder": "Clinical Chemistry"
}